Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

RSNA 2015

This year's RSNA 2015 in Chicago was the highlight of our trade fair activities and exceeded our expectations by far.

In addition to the structured reading procedures regarding Oncological Screening, Staging and Response Evaluation, we had the great possibility to present new customizable reading profiles. From now on, mint Lesion™ users have not only the possibility to use already implemented reading profiles, they are also able to create and adjust reading profiles according to their individual needs.

The next year is one we can look forward to and we wish to thank all our visitors - customers, interested parties and cooperation partners - for the positive feedback, interesting discussions and valuable input.

We are optimistically looking forward to the future and hope to see you all again soon!

Further information about mintLesion™ for

Related Resources

Related Resources

A doctor pushes a lying patient into the LDCT device

Early lung cancer detection through LDCT screening as a potential way to improve patient outcomes in Germany

The establishment of a nation-wide lung cancer screening program in Germany has been a subject of considerable interest and debate among healthcare…

A group of people standing together, looking up at the camera. The picture says: Together we're making an impact.

RACOON FHIR Workshop: Empowering Healthcare Research via Enhanced Interoperability

This week Brainlab hosted the RACOON FHIR Workshop with around 40 participants. The workshop was organized by Mint Medical and supported by Snke OS,…

A screenshot of a structured report from mint Lesion™

Tumor Growth Rate Modeling: A Novel Approach to Evaluating the Efficacy of Cancer Therapies

The 2020 review of Clinical Trial Evidence Supporting US Food and Drug Administrative Approval of Novel Cancer Therapies Between 2000 and 2016…